Cover Image

Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects

Taegon Hong,1,2 Seunghoon Han,1,2 Jongtae Lee,1,2 Sangil Jeon,1,2 Gab-Jin Park,1,2 Wan-Su Park,1,2 Kyoung Soo Lim,3 Jae-Yong Chung,4 Kyung-Sang Yu,3 Dong-Seok Yim1,2 1Department of Pharmacology, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea; 2PIPET (Pharmacometrics...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hong T (Author), Han S (Author), Lee J (Author), Jeon S (Author), Park GJ (Author), Park WS (Author), Lim KS (Author), Chung JY (Author), Yu KS (Author), Yim DS (Author)
Format:	Book
Published:	Dove Medical Press, 2015-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
by: Holger Michel, et al.
Published: (2023)

QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020)

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION
by: N. V. Furman, et al.
Published: (2015)

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION
by: N. V. Furman, et al.
Published: (2015)

Drug-induced QT interval prolongation in cancer patients
by: Torben K. Becker, et al.
Published: (2011)

Patient safety: prescription of drugs that prolong the QT interval
by: María Jesús Hernández-Arroyo, et al.
Published: (2015)

Serious QT interval prolongation associated with velafaxine administration
by: Pilar Tejedor Prado, et al.
Published: (2014)

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
by: Moon SJ, et al.
Published: (2019)

The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval
by: Ye Seung Lee, et al.
Published: (2015)

QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Shigeki Toyoshima, et al.
Published: (2005)

QT PRODACT: In Vivo QT Assay in Anesthetized Dog for Detecting the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Hiroyuki Tashibu, et al.
Published: (2005)

Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects
by: Jiang X, et al.
Published: (2023)

Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
by: Stefano Morotti
Published: (2018)

Propranolol can correct prolonged QT intervals in patients with cirrhosis
by: Huanqin Han, et al.
Published: (2024)

QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
by: Kentaro Ando, et al.
Published: (2005)

QT PRODACT: Sensitivity and Specificity of the Canine Telemetry Assay for Detecting Drug-Induced QT Interval Prolongation
by: Hiroyasu Miyazaki, et al.
Published: (2005)

X-Linked Cerebral Creatine Deficiency Syndrome with Prolonged QT Interval: A Case Report
by: Hye Won Kim, et al.
Published: (2022)

Analysis of the QT Interval Prolongation and Pharmaceuticals in Elderly Patients in Ambulatory Care
by: Nereida Ferraz Vieira do Prado, et al.
Published: (2024)

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
by: Onanong Waleekhachonloet, et al.
Published: (2019)

Cancer treatment and drug-induced QT interval prolongation: A review
by: Olga D. Ostroumova, et al.
Published: (2022)

Early Identification of Prolonged QT Interval for Prevention of Sudden Infant Death
by: Georgia Sarquella-Brugada, et al.
Published: (2021)

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers
by: Gu N, et al.
Published: (2014)

QT PRODACT: Usability of Miniature Pigs in Safety Pharmacology Studies: Assessment for Drug-Induced QT Interval Prolongation
by: Mayumi Kano, et al.
Published: (2005)

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects
by: Cha YJ, et al.
Published: (2014)

Prolongation of QT Interval in ECG: A Hidden Complication of Cirrhotic Liver Disease
by: Ajeet Kumar, et al.
Published: (2019)

Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose
by: Davood Soroosh, et al.
Published: (2019)

Clinical-pharmacological aspects of the safe use of medicines, causing prolongation of QT interval
by: O. A. Demidova, et al.
Published: (2018)

QT interval prolongation and rhabdomyolysis associated with diphenhydramine toxicity: a case report
by: Zain Ali, et al.
Published: (2020)

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects
by: Park SI, et al.
Published: (2015)

Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
by: Choi C, et al.
Published: (2018)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
by: Lee J, et al.
Published: (2014)

A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519
by: Choon Ok Kim, et al.
Published: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
by: B K Anupama MBBS, et al.
Published: (2020)

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects
by: Kim E, et al.
Published: (2019)

QT PRODACT: Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
by: Yoshihide Kii, et al.
Published: (2005)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
by: Hwang I, et al.
Published: (2020)

Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis
by: Ray W. Chui, et al.
Published: (2021)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
by: Rhee SJ, et al.
Published: (2016)

The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses
by: Joanna Parkinson, et al.
Published: (2024)

Sensitivity of inhalation anesthetics isoflurane and sevoflurane for the drug-induced QT-interval prolongation in guinea pigs
by: Yoshinobu Nagasawa, et al.
Published: (2020)